Emyria
ClaimedEmyria is a drug development and clinical care company focused on novel treatments for mental health and neurological conditions.
About
Emyria is an ASX-listed, data-backed drug development and care delivery company focused on unmet needs in mental health and neurological conditions. They combine frontline care with clinical research and real-world data to develop new therapies and breakthrough treatments, including psychedelic-assisted therapies and cannabinoid-based medicines. Emyria operates a network of specialist medical clinics and uses proprietary clinical evidence to accelerate drug development and registration.
Listed competitors
Also in this space
Global life sciences company providing diagnostic and biopharma laboratory services.
Shares HealthTech, Drug Discovery
Wearable devices and AI for continuous health monitoring and early disease detection.
Shares HealthTech, Mental Health Tech
Lunit is a medical AI company developing AI-powered solutions for cancer diagnostics and therapeutics.
Shares HealthTech, Biotech
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Shares Biotech, HealthTech
Data-driven software solutions for precision medicine and pharmaceutical development.
Shares HealthTech, Biotech
AI-powered breast cancer detection and risk assessment solutions.
Shares HealthTech, Biotech
Key facts
- Website
- emyria.com.au
- Headquarters
- Perth, Australia
- Founded
- 2019
- Business model
- B2B | B2C
Tech stack
Detected on emyria.com.au, last scanned 19 Oct 2026. Run your own scan
- Frontend
- Tailwind CSS
- CDN
- Cloudflare
Emyria scores 28. Does yours?
That is its Agent Readiness: how well ChatGPT, Claude and the other agents can read and use a site. Paste your website and you get yours in about a minute.
Frequently asked
Is Emyria trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Emyria is 56 out of 100, a use-caution rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Emyria

